[Federal Register Volume 61, Number 188 (Thursday, September 26, 1996)]
[Notices]
[Page 50491]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-244797]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Announcement of 
Meeting and Request for Comments on Proposed Incorporation of IPV/OPV 
Sequential Schedule Into the Vaccines for Children Program

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates:
      8:30 a.m.-6:00 p.m., October 23, 1996
      8:30 a.m.-1:15 p.m., October 24, 1996
    Place: CDC, Auditorium A, Building 2, 1600 Clifton Road, NE, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.

Purpose

    The Committee is charged with advising the Director, CDC, on the 
appropriate uses of immunizing agents. In addition, under 42 U.S.C. 
Sec. 1396s, the Committee is mandated to establish and periodically 
review and, as appropriate, revise, the list of vaccines for 
administration to vaccine-eligible children through the Vaccines for 
Children (VFC) Program, along with schedules regarding the appropriate 
periodicity, dosage, and contraindications applicable to the vaccines.

Matters to be Discussed

    Under the authority of 42 U.S.C. Sec. 1396s, the Committee will 
consider adoption of a resolution to incorporate into the VFC Program a 
recommended sequential schedule of inactivated poliovirus vaccine (IPV) 
followed by oral poliovirus vaccine (OPV), with schedules of OPV alone 
or IPV alone also being acceptable. This proposed VFC resolution is 
consistent with the Committee's general poliomyelitis recommendation 
that was adopted at the June 20, 1996, ACIP meeting.
    Given the considerable interest in the polio immunization schedule, 
opportunity for submitting written comments was provided and a public 
hearing was held prior to the Committee's adoption of their general 
poliomyelitis recommendation at the June 20 ACIP meeting. The Committee 
now invites submission of written comments on the proposed VFC 
resolution pertaining to incorporation of the sequential IPV/OPV 
schedule into the VFC Program. Copies of the proposed resolution are 
available by notifying the contact person. Copies will be sent 
electronically upon request. Written comments on the proposed 
resolution should be submitted to the contact person and must be 
received by October 18, 1996.
    Other topics to be discussed at the meeting include a draft 
statement on measles, mumps, and rubella (MMR); implementation of polio 
vaccination recommendation; acellular pertussis vaccines 
recommendations; recommendations for rabies postexposure prophylaxis 
(PEP); COMVAX (combined Hib and Hepatitis B vaccine); draft 
statement on the immunization of health care workers; varicella vaccine 
update; recommendations for strategies to increase immunization 
coverage; the National Immunization Survey (NIS); assessment and 
feedback of practice-based immunization coverage data; activation of 
HIV replication due to immunizations and acute illnesses; harmonization 
of the childhood immunization schedule; status of SmithKline Beecham 
Biological's candidate herpes simplex virus vaccine; update on Vaccine 
Injury Compensation Program; and the results of a study on influenza 
during pregnancy. Other matters of relevance among the Committee's 
objectives may be discussed.
    Agenda items are subject to change as priorities dictate.

CONTACT PERSON FOR MORE INFORMATION: Gloria A. Kovach, Committee 
Management Specialist, CDC (16-4346), 1600 Clifton Road, NE, Mailstop 
D50, Atlanta, Georgia 30333, telephone 404/639-7250.

    Dated: September 23, 1996.
Carolyn J. Russell,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 96-244797 Filed 9-25-96; 8:45 am]
BILLING CODE 4163-18-M